Tuesday, June 2, 2020

Strides Pharma gets USFDA nod for generic ointment to treat skin conditions

Strides Pharma gets USFDA nod for generic ointment to treat skin conditions The approval is granted to the company#39;s step-down wholly owned subsidiary, Strides Pharma Global, Singapore, by the United States Food and Drug Administration (USFDA) for triamcinolone acetonide ointment USP, 0.05 per cent, Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2Att3Ib
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Up to 28% fall in one month. Will US stagflation mean more bad news for Indian IT stocks?

The sharp drop in US consumer sentiment and persistent inflation concerns have triggered a selloff in Indian IT stocks, which have fallen up...